Emily J. Cox

849 total citations
31 papers, 605 citations indexed

About

Emily J. Cox is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Emily J. Cox has authored 31 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Emily J. Cox's work include Pancreatic function and diabetes (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and COVID-19 and healthcare impacts (3 papers). Emily J. Cox is often cited by papers focused on Pancreatic function and diabetes (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and COVID-19 and healthcare impacts (3 papers). Emily J. Cox collaborates with scholars based in United States, Canada and Australia. Emily J. Cox's co-authors include Susan A. Marsh, Radica Z. Alicic, Katherine R. Tuttle, Joshua J. Neumiller, Mary F. Paine, James M. Scanlan, Jashvant D. Unadkat, Allan E. Rettie, Jeannine S. McCune and Gabriela I. Patilea‐Vrana and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Emily J. Cox

31 papers receiving 600 citations

Peers

Countries citing papers authored by Emily J. Cox

Since Specialization

Citations

This map shows the geographic impact of Emily J. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily J. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily J. Cox more than expected).

Fields of papers citing papers by Emily J. Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily J. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily J. Cox. The network helps show where Emily J. Cox may publish in the future.

Co-authorship network of co-authors of Emily J. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Emily J. Cox. A scholar is included among the top collaborators of Emily J. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily J. Cox. Emily J. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder 2023 ·Drugs in R&D ·(unknown), (unknown), (unknown), Emily J. Cox, (unknown)	4
2	Who was at risk for COVID-19 late in the US pandemic? Insights from a population health machine learning model 2022 ·Medical & Biological Engineering & Computing ·(unknown), Yelena Rozenfeld, (unknown), (unknown), Emily J. Cox, James M. Scanlan	1
3	Patient experience and healthcare utilization for a COVID-19 telemedicine home monitoring program offered in English and Spanish 2022 ·PLoS ONE ·Keri B. Vartanian, Megan Holtorf, Emily J. Cox, George Diaz, (unknown), (unknown), (unknown), (unknown), Todd Czartoski	5
4	Comparison of 26-mm Evolut and 23-mm Sapien 3 Valves in TAVR for Small Aortic Annulus 2022 ·The Journal of invasive cardiology ·Ruyun Jin, Emily J. Cox, (unknown), (unknown), (unknown), Michael C. Reed, (unknown), Gary L. Grunkemeier, (unknown), Michael Ring	7
5	Modeling Pharmacokinetic Natural Product–Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach 2021 ·Pharmacological Reviews ·Emily J. Cox, Dandan Tian, John Clarke, Allan E. Rettie, Jashvant D. Unadkat, Kenneth E. Thummel, Jeannine S. McCune, Mary F. Paine	15
6	Comparing accuracy of bedside ultrasound examination with physical examination for detection of pleural effusion 2021 ·The Ultrasound Journal ·(unknown), (unknown), Emily J. Cox, (unknown), (unknown), (unknown), (unknown), Irene Ma	6
7	POCUS Evaluation in Acute Kidney Injury 2021 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Emily J. Cox, Kang Zhang	3
8	Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Glucagon-like Peptide-1 Receptor Agonists 2020 ·US Endocrinology ·Emily J. Cox, Radica Z. Alicic, Joshua J. Neumiller, Katherine R. Tuttle	7
9	Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence 2020 ·Nature Reviews Nephrology ·Radica Z. Alicic, Emily J. Cox, Joshua J. Neumiller, Katherine R. Tuttle	133
10	COVID-19 and Gastrointestinal Tract Symptoms: Recognition, Containment, and Learning From the Past 2020 ·Mayo Clinic Proceedings ·(unknown), Emily J. Cox, James M. Scanlan, Radica Z. Alicic	7
11	Put a lid on it: are faecal bio-aerosols a route of transmission for SARS-CoV-2? 2020 ·Journal of Hospital Infection ·(unknown), Radica Z. Alicic, (unknown), Emily J. Cox, James M. Scanlan	49
12	Prevalence of intra‐atrial reentrant tachycardia following mitral valve surgery: Relationship to surgical approach 2020 ·Journal of Cardiac Surgery ·(unknown), Emily J. Cox	2
13	Deep Brain Stimulation Generator Replacement in End-Stage Parkinson Disease 2019 ·World Neurosurgery ·Jonathan D. Carlson, (unknown), (unknown), Emily J. Cox, (unknown), (unknown), Jason Aldred	3
14	Investigating Risk Factors and Predicting Complications in Deep Brain Stimulation Surgery with Machine Learning Algorithms 2019 ·World Neurosurgery ·Farrokh Farrokhi, Quinlan D. Buchlak, (unknown), Nazanin Esmaili, (unknown), (unknown), (unknown), Emily J. Cox, Christine Bennett, Jonathan D. Carlson	41
15	Indinavir Increases Midazolam N-Glucuronidation in Humans: Identification of an Alternate CYP3A Inhibitor Using an In Vitro to In Vivo Approach 2019 ·Drug Metabolism and Disposition ·Dandan Tian, (unknown), Emily J. Cox, (unknown), Kosea S. Frederick, Yolanda V. Scarlett, Michael B. Fisher, Mary F. Paine	9
16	A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics 2019 ·Pharmacology & Therapeutics ·Emily J. Cox, (unknown), Gabriela I. Patilea‐Vrana, Jashvant D. Unadkat, Allan E. Rettie, Jeannine S. McCune, Mary F. Paine	70
17	Eye‐controlled, power wheelchair performs well for ALS patients 2019 ·Muscle & Nerve ·Michael A. Elliott, H.S. Malvar, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ann Paradiso, (unknown), (unknown), (unknown), Jeremy Chase Crawford, (unknown), Emily J. Cox, James M. Scanlan	19
18	Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy 2019 ·CNS Oncology ·Joshua Loya, (unknown), Emily J. Cox, Achal S. Achrol, Santosh Kesari	4
19	Consuming a Western diet for two weeks suppresses fetal genes in mouse hearts 2014 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·(unknown), Emily J. Cox, (unknown), Susan A. Marsh	8
20	A Systematic Review of Fetal Genes as Biomarkers of Cardiac Hypertrophy in Rodent Models of Diabetes 2014 ·PLoS ONE ·Emily J. Cox, Susan A. Marsh	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact